Bone Marrow Mononuclear Cell Therapy Led to Alveolar-Capillary Membrane Repair, Improving Lung Mechanics in Endotoxin-Induced Acute Lung Injury
Authors: Prota, Luiz Felipe M.; Lassance, Roberta M.; Maron-Gutierrez, Tatiana; Castiglione, Raquel C.; Garcia, Cristiane Souza Baez; Santana, Maria Cristina Ebole; Souza-Menezes, Jackson; Abreu, Soraia C.; Samoto, Vivian; Santiago, Marcelo Felipe; Capelozzi, Vera Luiza; Takiya, Christina Maeda; Rocco, Patricia R. M.; Morales, Marcelo M.
Source: Cell Transplantation, Volume 19, Number 8, August 2010 , pp. 965-971(7)
Publisher: Cognizant Communication Corporation
Abstract:The aim of this study was to test the hypothesis that bone marrow mononuclear cell (BMDMC) therapy led an improvement in lung mechanics and histology in endotoxin-induced lung injury. Twenty-four C57BL/6 mice were randomly divided into four groups (n = 6 each). In the acute lung injur;y (ALI) group, Escherichia coli lipopolysaccharide (LPS) was instilled intratracheally (40 μg, IT), and control (C) mice received saline (0.05 ml, IT). One hour after the administration of saline or LPS, BMDMC (2 × 107 cells) was intravenously injected. At day 28, animals were anesthetized and lung mechanics [static elastance (E st), resistive (P 1), and viscoelastic (P 2) pressures] and histology (light and electron microscopy) were analyzed. Immunogold electron microscopy was used to evaluate if multinucleate cells were type II epithelial cells. BMDMC therapy prevented endotoxin-induced lung inflammation, alveolar collapse, and interstitial edema. In addition, BMDMC administration led to epithelial and endothelial repair with multinucleated type II pneumocytes. These histological changes yielded a reduction in lung E st, P 1, and P 2 compared to ALI. In the present experimental ALI model, the administration of BMDMC yielded a reduction in the inflammatory process and a repair of epithelium and endothelium, reducing the amount of alveolar collapse, thus leading to an improvement in lung mechanics.
Document Type: Research Article
Publication date: August 1, 2010
- Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances, and ethical and regulatory considerations of cell transplants. Cell Transplantation is now an Open Access journal starting with volume 18 in 2009, and therefore there will be an inexpensive publication charge, which is dependent on the number of pages, in addition to the charge for color figures. This will allow work to be disseminated to a wider audience and also entitle the corresponding author to a free PDF, as well as prepublication of an unedited version of the manuscript.
- In this: publication
- By this: publisher
- In this Subject: Anatomy & Physiology , Biology , Biotechnology , Pharmacology , Surgery
- By this author: Prota, Luiz Felipe M. ; Lassance, Roberta M. ; Maron-Gutierrez, Tatiana ; Castiglione, Raquel C. ; Garcia, Cristiane Souza Baez ; Santana, Maria Cristina Ebole ; Souza-Menezes, Jackson ; Abreu, Soraia C. ; Samoto, Vivian ; Santiago, Marcelo Felipe ; Capelozzi, Vera Luiza ; Takiya, Christina Maeda ; Rocco, Patricia R. M. ; Morales, Marcelo M.